Suppr超能文献

经动脉血管介入放射学中肝素使用的当前趋势。

Current trends in heparin use during arterial vascular interventional radiology.

机构信息

Peninsula Radiology Academy, Plymouth International Business Park, Plymouth, PL6 5WR, UK.

出版信息

Cardiovasc Intervent Radiol. 2012 Dec;35(6):1308-14. doi: 10.1007/s00270-011-0337-1. Epub 2012 Jan 13.

Abstract

PURPOSE

This study was designed to assess the current use of heparinized saline and bolus doses of heparin in non-neurological interventional radiology and to determine whether consensus could be reached to produce guidance for heparin use during arterial vascular intervention.

METHODS

An interactive electronic questionnaire was distributed to members of the British Society of Interventional Radiology regarding their current practice in the use, dosage, and timing of heparin boluses and heparinized flushing solutions.

RESULTS

A total of 108 completed questionnaires were received. More than 80% of respondents used heparinized saline with varying concentrations; the most prevalent was 1,000 IU/l (international units of heparin per liter) and 5,000 IU/l. Fifty-one percent of interventionalists use 3,000 IU as their standard bolus dose; however, the respondents were split regarding the timing of bolus dose with ~60% administering it after arterial access is obtained and 40% after crossing the lesion. There was no consensus on altering dose according to body weight, and only 4% monitored clotting parameters.

CONCLUSIONS

There seems to be some coherence among practicing interventionalists regarding heparin administration. We hypothesize that heparinized saline should be used at a recognized standard concentration of 1,000 IU/l as a flushing concentration in all arterial vascular interventions and that 3,000 IU bolus is considered the standard dose for straightforward therapeutic procedures and 5000 IU for complex, crural, and endovascular aneurysm repair work. The bolus should be given after arterial access is obtained to allow time for optimal anticoagulation to be achieved by the time of active intervention and stenting. Further research into clotting abnormalities following such interventional procedures would be an interesting quantifiable follow-up to this initial survey of opinions and practice.

摘要

目的

本研究旨在评估肝素生理盐水和肝素推注剂量在非神经介入放射学中的当前应用,并确定是否可以达成共识,为动脉血管介入治疗期间的肝素使用提供指导。

方法

向英国介入放射学会成员分发了一份交互式电子问卷,了解他们在肝素推注剂量和时间以及肝素化冲洗液使用方面的当前实践情况。

结果

共收到 108 份完整的问卷。超过 80%的受访者使用不同浓度的肝素化生理盐水;最常见的是 1000IU/L(每升肝素的国际单位)和 5000IU/L。51%的介入医师使用 3000IU 作为标准推注剂量;然而,关于推注剂量的时机,受访者存在分歧,约 60%在获得动脉入路后给药,40%在穿过病变后给药。根据体重调整剂量没有共识,只有 4%监测凝血参数。

结论

在肝素给药方面,实践中的介入医师似乎存在一定的一致性。我们假设肝素生理盐水应在所有动脉血管介入治疗中使用公认的标准浓度 1000IU/L 作为冲洗浓度,3000IU 推注剂量被认为是简单治疗程序的标准剂量,5000IU 推注剂量用于复杂、小腿和血管内动脉瘤修复工作。应在获得动脉入路后给予推注,以便在积极干预和支架置入时达到最佳抗凝效果。对这种介入治疗后凝血异常的进一步研究将是对此初始意见和实践调查的有趣可量化随访。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验